Mastrantoni, Luca
 Distribuzione geografica
Continente #
EU - Europa 160
AS - Asia 96
NA - Nord America 65
SA - Sud America 29
AF - Africa 1
Totale 351
Nazione #
IT - Italia 89
US - Stati Uniti d'America 62
CN - Cina 34
SG - Singapore 33
BR - Brasile 27
DE - Germania 18
SE - Svezia 11
KR - Corea 10
FR - Francia 9
IN - India 9
FI - Finlandia 5
GB - Regno Unito 4
HK - Hong Kong 4
ID - Indonesia 4
IE - Irlanda 4
RU - Federazione Russa 4
AT - Austria 3
BE - Belgio 3
CA - Canada 2
CH - Svizzera 2
ES - Italia 2
NL - Olanda 2
AZ - Azerbaigian 1
CY - Cipro 1
CZ - Repubblica Ceca 1
LT - Lituania 1
MX - Messico 1
PL - Polonia 1
PT - Portogallo 1
PY - Paraguay 1
TN - Tunisia 1
VE - Venezuela 1
Totale 351
Città #
Rome 53
Singapore 24
Hefei 11
Seoul 10
The Dalles 10
Ashburn 9
New York 9
Bari 8
Hyderabad 8
Düsseldorf 7
Frankfurt am Main 6
Dublin 4
Falkenstein 4
Hong Kong 4
Jakarta 4
Milan 4
Moscow 4
North Bergen 4
Bexley 3
Boardman 3
Brussels 3
Helsinki 3
Campinas 2
Des Moines 2
Isorella 2
Lappeenranta 2
Los Angeles 2
Madrid 2
Ribeirão Preto 2
Rubano 2
São Paulo 2
Venice 2
Verdellino 2
Anguillara 1
Anzio 1
Asunción 1
Bagnoli del Trigno 1
Baku 1
Bauru 1
Belo Horizonte 1
Brno 1
Busto Arsizio 1
Campanha 1
Campo Grande 1
Campos Novos 1
Cristópolis 1
Cruz 1
Fazenda Rio Grande 1
Guaíba 1
Hortolândia 1
Ibirité 1
Itajaí 1
João Câmara 1
Juazeiro do Norte 1
Lauterbourg 1
Lisbon 1
Mesquita 1
Mexico City 1
Munich 1
Nicosia 1
Nova Granada 1
Ottawa 1
Paris 1
Porto Firme 1
Portsmouth 1
Roubaix 1
San Carlos 1
San Francisco 1
Santa Cecília 1
Santa Clara 1
Santa Luzia 1
Seattle 1
Stockholm 1
São Francisco do Sul 1
Toronto 1
Tunis 1
Viamão 1
Vienna 1
Vilnius 1
Washington 1
Wroclaw 1
Totale 265
Nome #
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis 71
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK-positive advanced nonsmall cell lung cancer 60
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program 53
Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC) 44
Risk of long Covid in children infected with Omicron or pre-Omicron SARS-CoV-2 variants 27
Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort study 23
Integrating clinical-molecular data to predict PARP inhibitors efficacy in advanced ovarian cancer patients after interval cytoreductive surgery 22
Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis 21
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy 16
Adjuvant denosumab in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trials 11
Maintenance strategies after anti-EGFR-based induction in metastatic colorectal cancer: A systematic review and bayesian network meta-analysis 10
COVALENCE STUDY: Immunogenicity and Reactogenicity of a COVID-19 mRNA Vaccine in an Open-Label Cohort of Long-Survivor Patients with Metastatic Lung Cancer 6
Totale 364
Categoria #
all - tutte 1.554
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.554


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20239 0 0 0 0 0 0 0 0 1 2 2 4
2023/202462 4 5 2 3 1 8 6 3 1 9 7 13
2024/2025293 3 2 10 29 7 12 19 8 40 43 110 10
Totale 364